The Role of Decidual Macrophages During Normal and Pathological Pregnancy

American Journal of Reproductive Immunology

Volumn 75, Issue 3, 2016, Pages 298-309

  Ning, Fen ^a   Liu, Huishu ^a,b   Lash, Gendie E ^a  

^a Guangzhou Women and Children's Medical Center   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Decidual macrophages; EVT invasion; pregnancy pathologies; spiral artery remodeling

Indexed keywords

ALPHA 2 MACROGLOBULIN; CD1 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; CD209 ANTIGEN; CD64 ANTIGEN; CD68 ANTIGEN; CD9 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; COLONY STIMULATING FACTOR 1; CXCL1 CHEMOKINE; GLYCOPROTEIN P 15095; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; L SELECTIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN D2; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; RELAXIN; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG;

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CELL MATURATION; CELL METABOLISM; CELL PROLIFERATION; CYTOKINE PRODUCTION; DECIDUA; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; INTRAUTERINE GROWTH RETARDATION; LIPID METABOLISM; MACROPHAGE; MONOCYTE; PHAGOCYTOSIS; PHENOTYPE; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY; PREGNANCY DISORDER; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; TROPHOBLAST; UPREGULATION;

EID: 84977525863     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12477     Document Type: Review

References (101)

1. Haldar M, Murphy KM: Origin, development, and homeostasis of tissue-resident macrophages. Immunol Rev 2014; 262:25–35.
2. Nahrendorf M, Swirski FK: Monocyte and macrophage heterogeneity in the heart. Circ Res 2013; 112:1624–1633.
3. Care AS, Diener KR, Jasper MJ, Brown HM, Ingman WV, Robertson SA: Macrophages regulate corpus luteum development during embryo implantation in mice. J Clin Invest 2013; 123:3472–3487.
4. Gordon S, Pluddemann A, Martinez EF: Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol Rev 2014; 262:36–55.
5. Mosser DM, Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8:958–969.
6. Gordon S, Taylor PR: Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5:953–964.
7. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, Scherberich J, Schmitz J, Shortman K, Sozzani S, Strobl H, Zembala M, Austyn JM, Lutz MB: Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116:e74–e80.
8. Massberg S, Schaerli P, Knezevic-Maramica I, Kollnberger M, Tubo N, Moseman EA, Huff IV, Junt T, Wagers AJ, Mazo IB, von Andrian UH: Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 2007; 131:994–1008.
9. Italiani P, Boraschi D: From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol 2014; 5:514.
10. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, Mack M, Charo IF: Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007; 117:902–909.
11. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G, Geissmann F: Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007; 317:666–670.
12. Faas MM, Spaans F, De Vos P: Monocytes and macrophages in pregnancy and pre-eclampsia. Front Immunol 2014; 5:298.
13. Epelman S, Lavine KJ, Randolph GJ: Origin and functions of tissue macrophages. Immunity 2014; 41:21–35.
14. van Furth R, Cohn ZA: The origin and kinetics of mononuclear phagocytes. J Exp Med 1968; 128:415–435.
15. Gautier EL, Yvan-Charvet L: Understanding macrophage diversity at the ontogenic and transcriptomic levels. Immunol Rev 2014; 262:85–95.
16. Van Furth R, Diesselhoff-den DM, Mattie H: Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction. J Exp Med 1973; 138:1314–1330.
17. Robbins CS, Chudnovskiy A, Rauch PJ, Figueiredo JL, Iwamoto Y, Gorbatov R, Etzrodt M, Weber GF, Ueno T, van Rooijen N, Mulligan-Kehoe MJ, Libby P, Nahrendorf M, Pittet MJ, Weissleder R, Swirski FK: Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation 2012; 125:364–374.
18. Wynn TA, Chawla A, Pollard JW: Macrophage biology in development, homeostasis and disease. Nature 2013; 496:445–455.
19. Colin S, Chinetti-Gbaguidi G, Staels B: Macrophage phenotypes in atherosclerosis. Immunol Rev 2014; 262:153–166.
20. Renaud SJ, Graham CH: The role of macrophages in utero-placental interactions during normal and pathological pregnancy. Immunol Invest 2008; 37:535–564.
21. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145–173.
22. Mantovani A, Sica A, Locati M: Macrophage polarization comes of age. Immunity 2005; 23:344–346.
23. Nishida M, Fujinaka H, Matsusaka T, Price J, Kon V, Fogo AB, Davidson JM, Linton MF, Fazio S, Homma T, Yoshida H, Ichikawa I: Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest 2002; 110:1859–1868.
24. Zhang G, Kim H, Cai X, Lopez-Guisa JM, Carmeliet P, Eddy AA: Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy. J Am Soc Nephrol 2003; 14:1234–1253.
25. Stein M, Keshav S, Harris N, Gordon S: Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992; 176:287–292.
26. Mantovani A, Garlanda C, Locati M: Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol 2009; 29:1419–1423.
27. Hume DA: The many alternative faces of macrophage activation. Front Immunol 2015; 6:370.
28. Rolls A, Shechter R, London A, Segev Y, Jacob-Hirsch J, Amariglio N, Rechavi G, Schwartz M: Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med 2008; 5:e171.
29. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003; 3:23–35.
30. Gordon S, Martinez FO: Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32:593–604.
31. Pauleau AL, Rutschman R, Lang R, Pernis A, Watowich SS, Murray PJ: Enhancer-mediated control of macrophage-specific arginase I expression. J Immunol 2004; 172:7565–7573.
32. Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MP, Donners MM: Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis 2014; 17:109–118.
33. Mahdavian DB, van der Veer WM, van Egmond M, Niessen FB, Beelen RH: Macrophages in skin injury and repair. Immunobiology 2011; 216:753–762.
34. Spencer M, Yao-Borengasser A, Unal R, Rasouli N, Gurley CM, Zhu B, Peterson CA, Kern PA: Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am J Physiol Endocrinol Metab 2010; 299:E1016–E1027.
35. Sierra-Filardi E, Vega MA, Sanchez-Mateos P, Corbi AL, Puig-Kroger A: Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. Immunobiology 2010; 215:788–795.
36. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, Senior RM, Elias JA: Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 2001; 194:809–821.
37. Zizzo G, Hilliard BA, Monestier M, Cohen PL: Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol 2012; 189:3508–3520.
38. Zizzo G, Cohen PL: IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids. J Immunol 2013; 190:5237–5246.
39. Grinberg S, Hasko G, Wu D, Leibovich SJ: Suppression of PLCbeta2 by endotoxin plays a role in the adenosine A(2A) receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotype. Am J Pathol 2009; 175:2439–2453.
40. Ferrante CJ, Pinhal-Enfield G, Elson G, Cronstein BN, Hasko G, Outram S, Leibovich SJ: The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Ralpha) signaling. Inflammation 2013; 36:921–931.
41. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D: Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum Reprod 1991; 6:791–798.
42. Bulmer JN, Williams PJ, Lash GE: Immune cells in the placental bed. Int J Dev Biol 2010; 54:281–294.
43. Klentzeris LD, Bulmer JN, Warren A, Morrison L, Li TC, Cooke ID: Endometrial lymphoid tissue in the timed endometrial biopsy: morphometric and immunohistochemical aspects. Am J Obstet Gynecol 1992; 167:667–674.
44. Repnik U, Tilburgs T, Roelen DL, van der Mast BJ, Kanhai HH, Scherjon S, Claas FH: Comparison of macrophage phenotype between decidua basalis and decidua parietalis by flow cytometry. Placenta 2008; 29:405–412.
45. Rieger L, Honig A, Sutterlin M, Kapp M, Dietl J, Ruck P, Kammerer U: Antigen-presenting cells in human endometrium during the menstrual cycle compared to early pregnancy. J Soc Gynecol Investig 2004; 11:488–493.
46. Houser BL, Tilburgs T, Hill J, Nicotra ML, Strominger JL: Two unique human decidual macrophage populations. J Immunol 2011; 186:2633–2642.
47. Bulmer JN, Johnson PM: Macrophage populations in the human placenta and amniochorion. Clin Exp Immunol 1984; 57:393–403.
48. Lessin DL, Hunt JS, King CR, Wood GW: Antigen expression by cells near the maternal-fetal interface. Am J Reprod Immunol Microbiol 1988; 16:1–7.
49. Vince GS, Starkey PM, Jackson MC, Sargent IL, Redman CW: Flow cytometric characterisation of cell populations in human pregnancy decidua and isolation of decidual macrophages. J Immunol Methods 1990; 132:181–189.
50. Kabawat SE, Mostoufi-Zadeh M, Driscoll SG, Bhan AK: Implantation site in normal pregnancy. A study with monoclonal antibodies. Am J Pathol 1985; 118:76–84.
51. Abrahams VM, Kim YM, Straszewski SL, Romero R, Mor G: Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol 2004; 51:275–282.
52. Jaiswal MK, Mallers TM, Larsen B, Kwak-Kim J, Chaouat G, Gilman-Sachs A, Beaman KD: V-ATPase upregulation during early pregnancy: a possible link to establishment of an inflammatory response during preimplantation period of pregnancy. Reproduction 2012; 143:713–725.
53. Mor G, Cardenas I, Abrahams V, Guller S: Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci 2011; 1221:80–87.
54. Gustafsson C, Mjosberg J, Matussek A, Geffers R, Matthiesen L, Berg G, Sharma S, Buer J, Ernerudh J: Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One 2008; 3:e2078.
55. Laskarin G, Cupurdija K, Tokmadzic VS, Dorcic D, Dupor J, Juretic K, Strbo N, Crncic TB, Marchezi F, Allavena P, Mantovani A, Randic L, Rukavina D: The presence of functional mannose receptor on macrophages at the maternal-fetal interface. Hum Reprod 2005; 20:1057–1066.
56. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL: Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198:1201–1212.
57. Burk MR, Troeger C, Brinkhaus R, Holzgreve W, Hahn S: Severely reduced presence of tissue macrophages in the basal plate of pre-eclamptic placentae. Placenta 2001; 22:309–316.
58. Soilleux EJ, Morris LS, Leslie G, Chehimi J, Luo Q, Levroney E, Trowsdale J, Montaner LJ, Doms RW, Weissman D, Coleman N, Lee B: Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 2002; 71:445–457.
59. Kammerer U, Eggert AO, Kapp M, McLellan AD, Geijtenbeek TB, Dietl J, van Kooyk Y, Kampgen E: Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am J Pathol 2003; 162:887–896.
60. Lidstrom C, Matthiesen L, Berg G, Sharma S, Ernerudh J, Ekerfelt C: Cytokine secretion patterns of NK cells and macrophages in early human pregnancy decidua and blood: implications for suppressor macrophages in decidua. Am J Reprod Immunol 2003; 50:444–452.
61. Houser BL: Decidual macrophages and their roles at the maternal-fetal interface. Yale J Biol Med 2012; 85:105–118.
62. Svensson J, Jenmalm MC, Matussek A, Geffers R, Berg G, Ernerudh J: Macrophages at the fetal-maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. J Immunol 2011; 187:3671–3682.
63. Aldo PB, Racicot K, Craviero V, Guller S, Romero R, Mor G: Trophoblast induces monocyte differentiation into CD14+/CD16+ macrophages. Am J Reprod Immunol 2014; 72:270–284.
64. Harris LK: IFPA Gabor Than Award lecture: transformation of the spiral arteries in human pregnancy: key events in the remodelling timeline. Placenta 2011; 32(Suppl. 2):S154–S158.
65. Bockle BC, Solder E, Kind S, Romani N, Sepp NT: DC-sign+ CD163+ macrophages expressing hyaluronan receptor LYVE-1 are located within chorion villi of the placenta. Placenta 2008; 29:187–192.
66. Han G, Chen G, Shen B, Li Y: Tim-3: an activation marker and activation limiter of innate immune cells. Front Immunol 2013; 4:449.
67. Ferenbach D, Hughes J: Macrophages and dendritic cells: what is the difference? Kidney Int 2008; 74:5–7.
68. Jokhi PP, King A, Boocock C, Loke YW: Secretion of colony stimulating factor-1 by human first trimester placental and decidual cell populations and the effect of this cytokine on trophoblast thymidine uptake in vitro. Hum Reprod 1995; 10:2800–2807.
69. Lockwood CJ, Matta P, Krikun G, Koopman LA, Masch R, Toti P, Arcuri F, Huang ST, Funai EF, Schatz F: Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia. Am J Pathol 2006; 168:445–452.
70. Arcuri F, Buchwalder L, Toti P, Cintorino M, Tosi P, Lockwood CJ, Rybalov B, Schatz F: Differential regulation of colony stimulating factor 1 and macrophage migration inhibitory factor expression by inflammatory cytokines in term human decidua: implications for macrophage trafficking at the fetal-maternal interface. Biol Reprod 2007; 76:433–439.
71. Hamilton JA: Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008; 8:533–544.
72. Drake PM, Gunn MD, Charo IF, Tsou CL, Zhou Y, Huang L, Fisher SJ: Human placental cytotrophoblasts attract monocytes and CD56(bright) natural killer cells via the actions of monocyte inflammatory protein 1alpha. J Exp Med 2001; 193:1199–1212.
73. Abrahams VM, Visintin I, Aldo PB, Guller S, Romero R, Mor G: A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol 2005; 175:8096–8104.
74. Svensson-Arvelund J, Mehta RB, Lindau R, Mirrasekhian E, Rodriguez-Martinez H, Berg G, Lash GE, Jenmalm MC, Ernerudh J: The human fetal placenta promotes tolerance against the semiallogeneic fetus by inducing regulatory T cells and homeostatic M2 macrophages. J Immunol 2015; 194:1534–1544.
75. Lee CL, Guo Y, So KH, Vijayan M, Guo Y, Wong VH, Yao Y, Lee KF, Chiu PC, Yeung WS: Soluble human leukocyte antigen G5 polarizes differentiation of macrophages toward a decidual macrophage-like phenotype. Hum Reprod 2015; 30:2263–2274.
76. Champion H, Innes BA, Robson SC, Lash GE, Bulmer JN: Effects of interleukin-6 on extravillous trophoblast invasion in early human pregnancy. Mol Hum Reprod 2012; 18:391–400.
77. De M, Wood GW: Influence of oestrogen and progesterone on macrophage distribution in the mouse uterus. J Endocrinol 1990; 126:417–424.
78. Tibbetts TA, Conneely OM, O'Malley BW: Progesterone via its receptor antagonizes the pro-inflammatory activity of estrogen in the mouse uterus. Biol Reprod 1999; 60:1158–1165.
79. Weiss G, Goldsmith LT: Mechanisms of relaxin-mediated premature birth. Ann N Y Acad Sci 2005; 1041:345–350.
80. Goldsmith LT, Weiss G, Palejwala S, Plant TM, Wojtczuk A, Lambert WC, Ammur N, Heller D, Skurnick JH, Edwards D, Cole DM: Relaxin regulation of endometrial structure and function in the rhesus monkey. Proc Natl Acad Sci USA 2004; 101:4685–4689.
81. Glass CK: Genetic and genomic approaches to understanding macrophage identity and function. Arterioscler Thromb Vasc Biol 2015; 35:755–762.
82. Smith SD, Dunk CE, Aplin JD, Harris LK, Jones RL: Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am J Pathol 2009; 174:1959–1971.
83. Robson A, Harris LK, Innes BA, Lash GE, Aljunaidy MM, Aplin JD, Baker PN, Robson SC, Bulmer JN: Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. FASEB J 2012; 26:4876–4885.
84. Heikkinen J, Mottonen M, Komi J, Alanen A, Lassila O: Phenotypic characterization of human decidual macrophages. Clin Exp Immunol 2003; 131:498–505.
85. Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, Huppertz B: Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 2001; 81:1143–1152.
86. Mor G, Abrahams VM: Potential role of macrophages as immunoregulators of pregnancy. Reprod Biol Endocrinol 2003; 1:119.
87. Redline RW, Lu CY: Specific defects in the anti-listerial immune response in discrete regions of the murine uterus and placenta account for susceptibility to infection. J Immunol 1988; 140:3947–3955.
88. Renaud SJ, Postovit LM, Macdonald-Goodfellow SK, McDonald GT, Caldwell JD, Graham CH: Activated macrophages inhibit human cytotrophoblast invasiveness in vitro. Biol Reprod 2005; 73:237–243.
89. Huang SJ, Chen CP, Schatz F, Rahman M, Abrahams VM, Lockwood CJ: Pre-eclampsia is associated with dendritic cell recruitment into the uterine decidua. J Pathol 2008; 214:328–336.
90. Lash GE, Burton GJ, Chamley LW, Clifton VL, Constancia M, Crocker IP, Dantzer V, Desoye G, Drewlo S, Hemmings DG, Hiendleder S, Kalionis B, Keelan JA, Kudo Y, Lewis RM, Manuelpillai U, Murthi P, Natale D, Pfarrer C, Robertson S, Saffery R, Saito S, Sferruzzi-Perri A, Sobrevia L, Waddell BJ, Roberts CT: IFPA Meeting 2009 workshops report. Placenta 2010; 31(Suppl.):S4–S20.
91. Burton GJ, Jauniaux E: Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 2004; 11:342–352.
92. Reister F, Frank HG, Heyl W, Kosanke G, Huppertz B, Schroder W, Kaufmann P, Rath W: The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta 1999; 20:229–233.
93. Wilczynski JR, Tchorzewski H, Glowacka E, Banasik M, Lewkowicz P, Szpakowski M, Zeman K, Wilczynski J: Cytokine secretion by decidual lymphocytes in transient hypertension of pregnancy and pre-eclampsia. Mediators Inflamm 2002; 11:105–111.
94. Postovit LM, Adams MA, Graham CH: Does nitric oxide play a role in the etiology of pre-eclampsia? Placenta 2001; 22(Suppl. A):S51–S55.
95. Pathak N, Sawhney H, Vasishta K, Majumdar S: Estimation of oxidative products of nitric oxide (nitrates, nitrites) in preeclampsia. Aust N Z J Obstet Gynaecol 1999; 39:484–487.
96. Lash GE, Otun HA, Innes BA, Bulmer JN, Searle RF, Robson SC: Inhibition of trophoblast cell invasion by TGFB1, 2, and 3 is associated with a decrease in active proteases. Biol Reprod 2005; 73:374–381.
97. Straszewski-Chavez SL, Abrahams VM, Mor G: The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr Rev 2005; 26:877–897.
98. Fadok VA, Chimini G: The phagocytosis of apoptotic cells. Semin Immunol 2001; 13:365–372.
99. Van Ginderachter JA, Movahedi K, Hassanzadeh GG, Meerschaut S, Beschin A, Raes G, De Baetselier P: Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology 2006; 211:487–501.
100. Minas V, Jeschke U, Kalantaridou SN, Richter DU, Reimer T, Mylonas I, Friese K, Makrigiannakis A: Abortion is associated with increased expression of FasL in decidual leukocytes and apoptosis of extravillous trophoblasts: a role for CRH and urocortin. Mol Hum Reprod 2007; 13:663–673.
101. Straszewski-Chavez SL, Abrahams VM, Funai EF, Mor G: X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis. Mol Hum Reprod 2004; 10:33–41.